Eurofins Scientific has reached an agreement with Element Materials Technology to acquire its Life Sciences Testing Services business in North America, for an enterprise value of $400m. The transaction is subject to customary conditions, including regulatory approvals, and is expected to close in Q4 2026..

欧陆科技集团已与Element Materials Technology达成协议，以4亿美元的企业价值收购其北美生命科学测试服务业务。该交易须满足惯例条件，包括获得监管批准，预计将于2026年第四季度完成。

Element’s North America Life Sciences Testing Services includes a range of Biopharma product testing, Environmental testing and Food testing services, offered by a network of 27 laboratories and facilities. It employs approximately 750 FTEs, and is expected to generate annual revenues of over $150m in 2026, with profitability similar to the Eurofins Group average..

Element的北美生命科学检测服务涵盖一系列生物制药产品检测、环境检测和食品检测服务，由遍布各地的27家实验室和设施网络提供。该业务部门拥有约750名全职员工，预计2026年年度收入将超过1.5亿美元，利润率与Eurofins集团平均水平相当。

This addition to Eurofins’ BioPharma and Life businesses in North America will expand the geographic presence of Eurofins’ laboratories network into certain key regions of the United States and Canada where Eurofins has historically been underrepresented. The acquired operations will benefit from access to the breadth of customer offering and the economies of scale of Eurofins’ established hub-and-spoke laboratory networks.

此次对Eurofins在北美地区的生物制药和生命科学业务的补充，将扩大Eurofins实验室网络在美国和加拿大某些关键地区的地理覆盖范围，这些地区历史上Eurofins的代表性不足。被收购的业务将受益于Eurofins成熟的中心辐射式实验室网络所提供的广泛客户产品和服务以及规模经济优势。

The transaction aligns with Eurofins’ ongoing focus on allocating capital towards its core testing for life capabilities..

此次交易符合欧陆集团持续将资本配置于其核心“检测服务，助力生命”业务的战略重点。

Comment from Dr Gilles Martin, Eurofins CEO: “We look forward to welcoming Element’s North American Life Sciences Testing Services teams into Eurofins. This acquisition is a natural fit with Eurofins’ existing businesses, and can build on our well invested, efficient and digital laboratories platform to help drive unique levels of service to customers across the continent.”.

Eurofins 首席执行官吉勒·马丁博士表示：“我们期待欢迎 Element 的北美生命科学检测服务团队加入 Eurofins。此次收购与 Eurofins 现有业务高度契合，我们将依托已充分投资、高效且数字化的实验室平台，为整个北美的客户提供独具优势的服务水平。”

https://www.bionity.com/en/news/1189368/eurofins-acquires-element-s-biopharma-and-food-testing-capabilities-in-north-america.html

https://www.bionity.com/en/news/1189368/eurofins-acquires-element-s-biopharma-and-food-testing-capabilities-in-north-america.html

$400 million deal: Eurofins acquires Element Materials Technology's Life Sciences Testing Services business in North America

4亿美元交易：Eurofins收购Element Materials Technology在北美地区的生命科学检测服务业务

The transaction involves biopharma, environmental, and food testing

该交易涉及生物制药、环境和食品检测

Read news

阅读新闻

Most read news

阅读最多的新闻

1

1

Inducing cell death in pancreatic cancer cells

诱导胰腺癌细胞死亡

2

2

Breakthrough in tailor-made enzyme design

定制酶设计取得突破

3

3

The Kitchen Sponge: A Microcosm—Bacterial Contamination Isn't Always Visible, Smellable, or Palpable

厨房海绵：一个微观世界——细菌污染并不总是可见、可嗅或可触的

4

4

New drug could slow the development of Alzheimer’s

新药或可延缓阿尔茨海默病的发展

5

5

Strüngmann Award 2026: Who is transforming the life sciences in the DACH region?

2026年斯特伦曼奖：谁正在改变德语区（DACH）的生命科学领域？

Topics

主题

laboratory digitalization

实验室数字化

food testing

食品检测

product testing

产品测试

environmental testing

环境测试

Show all

显示全部

Show less

显示较少

Organizations

组织

Element Materials Technology

元素材料技术

Eurofins Scientific

欧陆科技集团